Related Experiment Video
Updated: Jun 28, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Alpha-1 deficiency in severe asthma patients.
M Zappa1, S Grossi2, P Pignatti3
1Department of Medicine and Surgery, University of Insubria, Varese.
Severe asthma patients with non-MM Alpha-1 antitrypsin (AAT) deficiency genotypes show lower AAT levels and higher emphysema. MM genotype patients experienced better symptom control and reduced inflammation during follow-up.
Area of Science:
- Pulmonology
- Genetics
- Internal Medicine
Background:
- Alpha-1 antitrypsin (AAT) deficiency is an autosomal co-dominant condition affecting protein levels.
- The influence of specific SERPINA1 gene phenotypes on severe asthma outcomes requires further investigation.
Purpose of the Study:
- To compare disease control, inflammation, lung function, and comorbidities in severe asthma patients with non-MM SERPINA1 genotypes versus MM genotypes.
- To determine if SERPINA1 genotype impacts the follow-up of severe asthma patients.
Main Methods:
- Retrospective analysis of 73 severe asthma patients (GINA step 5) in an Italian clinic.
- Collection of clinical, biological, and functional data at baseline and over three years.
- Comparison between patients with non-MM (n=14) and MM (n=59) SERPINA1 genotypes.
Main Results:
- Non-MM genotype patients had lower serum AAT concentration and higher emphysema prevalence at baseline.
- Only MM genotype patients demonstrated significant improvement in Asthma Control Questionnaire (ACQ-6) scores.
- MM genotype patients also showed significant reduction in eosinophilic systemic inflammation during follow-up.
Conclusions:
- SERPINA1 genotype influences the clinical course and management of severe asthma.
- Screening for AAT deficiency is crucial in severe asthma patients to identify individuals who may benefit from specific monitoring or interventions.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Asthma-III: Symptoms and Complications
Classification of Asthma
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

